CURE vs IVV
Direxion Daily Healthcare Bull 3X ETF vs iShares Core S&P 500 ETF
Quick Verdict
IVV has a lower expense ratio. CURE delivered stronger 1-year returns. IVV offers more diversification with 505 holdings.
Side-by-Side Comparison
| Metric | CURE | IVV | Winner |
|---|---|---|---|
| Expense Ratio | 0.94% | 0.03% | |
| AUM | $181M | $865.2B | |
| Dividend Yield | 1.12% | 1.09% | |
| Holdings | 67 | 508 | |
| YTD Return | +15.97% | +13.43% | |
| 1Y Return | +89.64% | +22.61% | |
| 3Y Return (annualized) | +8.52% | +21.47% | |
| 5Y Return (annualized) | +2.88% | +13.26% | |
| Volatility (annualized) | 41.9% | 15.1% | |
| Max Drawdown | -69.2% | -56.5% | |
| Fund Family | Direxion Shares ETF Trust | iShares by BlackRock (US) | |
| Category | Alternative | Equity | |
| Inception | Jun 15, 2011 | May 15, 2000 |
CURE vs IVV Performance
Direxion Daily Healthcare Bull 3X ETF (CURE) is a ETF from Direxion Shares ETF Trust and iShares Core S&P 500 ETF (IVV) is a ETF from iShares by BlackRock (US). Over the past year CURE returned +89.64% while IVV returned +22.61%. Year to date, CURE is up 15.97% versus a gain of 13.43% for IVV.
Over three years, CURE compounded at +8.52% per year against +21.47% for IVV; over five years the annualized figures are +2.88% and +13.26% respectively. Across the full 15-year window we track, CURE has the edge at +24.48% annualized vs +7.03%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
CURE has been the more volatile fund, with annualized monthly volatility of 41.9% compared with 15.1% for IVV. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -69.2% for CURE and -56.5% for IVV. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.73. They usually move together, but the gap leaves some room for diversification.
Fees and Cost Over Time
CURE charges 0.94% per year while IVV charges 0.03%. On a $10,000 position that is $94 vs $3 annually, a gap of $91 per year that compounds over a long holding period. On income, CURE currently yields 1.12% against 1.09% for IVV.
Holdings Overlap
CURE and IVV share 59 holdings out of 508 unique holdings combined, representing a 8.9% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, CURE or IVV?
CURE has an expense ratio of 0.94% while IVV charges 0.03%. IVV is the cheaper option. On a $10,000 investment, that is $91 per year of difference.
Which performed better, CURE or IVV?
Over the past year CURE returned +89.64% vs +22.61% for IVV, so CURE leads on 1-year performance. Over the longest common window we track (15 years), CURE annualized +24.48% vs +7.03% for IVV. Past performance does not guarantee future results.
Which is riskier, CURE or IVV?
CURE has been the more volatile fund at 41.9% annualized versus 15.1% for IVV. Worst drawdown: CURE -69.2% vs IVV -56.5%.
Should I hold both CURE and IVV?
CURE and IVV have a monthly-return correlation of 0.73, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between CURE and IVV?
CURE and IVV share 59 common holdings with a 8.9% weight overlap. Combined, they hold 508 unique securities.
Which pays a higher dividend, CURE or IVV?
CURE yields 1.12% while IVV yields 1.09%, so CURE currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.